Buradasınız

Anasayfa » Content

GİNGİVADA PEMFİGUS VULGARİS'İN ERKEN LEZYONLARI*: OLGU SUNUMU

EARLY LESIONS OF PEMPHIGUS VULGARIS IN GINGIVA: A CASE REPORT

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 2006

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Pemfigus vulgaris (PV), an autoimmune disorder characterized by the formation of intraepithelial vesicles and bullae and affecting the mucous membranes and skin, is the most common form of pemfigus. Though oral findings may occur in almost all cases, lesions often first appear in oral mucosa. The PV case presented here was diagnosed while the lesions were yet limited to the oral mucosa, and a better prognosis was ensured with treatment started at an early phase. In our presentation of the case, the responsibilities of the dentists for diagnosing PV come to the fore and the importance of a careful clinical inspection, anamnesis and patient follow-up against the varied clinical forms of initial lesions of PV is emphasized.
Bookmark/Search this post with
Abstract (Original Language): 
Pemligus vulgaris (PV) , müköz membranlan ve deriyi etkileyen, intraepitelyal vezikül ve bül oluşumuyla karakterize otoimmün bir hastalık olup pemfigusun en yaygın görülen formudur. Hemen her olguda oral bulgulara rastlanmakla birlikte klinikte dikkat çeken, olguların çoğunluğunda lezyonlann ilk olarak oral mukozada başlamasıdır. Bu yazıda, lezyonlar henüz oral mukozaya sınırlı iken teşhis edilmiş ve erken evrede tedaviye başlanıp daha iyi bir prognoz sağlanmış bir PV olgusu sunulmaktadır. Sunulan olguda, özellikle diş hekimlerinin PV'yi teşhis etme hususundaki sorumluluğu ön plana çıkmakta ve PV'nin başlangıç lezyonlannın değişik klinik görünümlerine karşı dikkatli bir klinik muayene, anamnez ve hasta takibinin önemi vurgulanmaktadır.
FULL TEXT (PDF): 
PDF icon arastirmax-gingivada-pemfigus-vulgarisin-erken-lezyonlari-olgu-sunumu.pdf
  • 3-4
37
42
  • Turkish

REFERENCES

References: 

1. Shelley W, Crissey J. In: Wilan R, editor. Classics in Clinical Dermatology. Springfield (IL): C.C Thomas. 1970; p. 17.
2. Scully C, Challacombe SJ. Pemphigus Vulgaris: Update on Etiopathogenesis, Oral Manifestations and Management. Crit Rev Oral Biol Med. 2002; 13 (5): 397-408.
3. Greenberg MS. Ulcerative, Vesicular and Bullous Lesions. In: Greenberg MS, Glick M, eds. Burket's Oral Medicine, ed 10. Ontorio: BC Decker, 2003; p. 50-84.
4. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L, et al. Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia. N Engl J Med, 1990; 323: 1729-35.
5. Sklavounou A, Laskaris G. Paraneoplastic Pemphigus: A Review. Oral Oncol, 1998; 35:437-40.
6. Nishikawa T, Hashimoto T, Shimizu H, Ebihara T, Amagai M. Pemphigus: from Immunofluorescence to Molecular Biology. J Dermatol Sci, 1996; 12: 1-9.
7. Becker BA, Gaspari AA. Pemphigus Vulgaris and Vegetans. Dermatol Clin, 1993; 11: 453-62.
8. Field A, Longman L, Tyldesley WR. Tyldesley's Oral Medicine, ed 5. New York: Oxford, 2003; p. 125-39.
9. Laskaris G, Stoufi E. Oral Pemphigus Vulgaris in a 6-Year-Old Girl. Oral Surg Oral Med Oral Pathol. 1990; 69: 609-13.
10. Eller J, Kest L. Pemphigus: Repon of Seventy-Seven Cases. Arch Dermatol. 1941; 44: 337-44.
11. Gellis S, Glass F. Pemphigus, a Survey of One Hundred and Seventy Patients Admitted to Bellevue Hospital from 1911-1941. Arch Dermatol, 1941; 44: 321-36.
12. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus Vulgaris: Incidence in Jews of different ethnic groups, according to age. sex and initial lesion. Oral Surg Oral Med Oral Pathol, 1974; 38: 382-7.
13. Krain LS, Terasaki PI, Newcomer VD, Mickey MR. Increased Frequency of HLA-A10 in Pemphigus Vulgaris. Arch Dermatol, 1973; 108: 803-5.
14. Park MS, Terasaki PI, Ahmed AR, Tiwari JL. HLA-DRW4 in 91% of Jewish Pemphigus Vulgaris Patients. Lancet, 1979; 2: 441-2.
15. Tron F, Gilbert D, Mouquet H, Joly P. Drouot L, Makni S, Masmoudi H, Charron D, Zitouni M, Loiseau P, Ben Ayed M. Genetic Factors in Pemphigus. J Autoimmun, 2005; 24 (4): 319-28.
16.
Tanyeri H. Oral Mukozanın İmmünolojik Hastalıkları ve Tedavileri. İstanbul: Nobel, 2000; s. 69-75.
17. Ruocco E, Baroni A, Wolf R. Vincenzo R. Life-Threatening Bullous Dermatoses: Pemphigus Vulgaris. Clin Dermatol, 2005; 23 (3): 223-6.
18.
Ünür M, Doğan Onur O. Ağız Hastalıklarının Teşhis ve Tedavisi. İstanbul: Quintessence, 2003; s. 223-5.
19. Lewinson W. Jawetz E. Medical Microbiology & Immunology: Examination & Board Review, ed 7. San Francisco:McGraw-Hill. 2002; p. 427.
20.
Yücetaş Ş. Ağız ve Çevre Dokusu Hastalıkları. Ankara: Atlas, 2005; s. 366-7.
21.
Özbayrak S. Ağız Hastalıkları Atlası: Tanı Kriterleri, Ayırıcı Tanı ve Tedavi Yaklaşımları. İstanbul: Quintessence, 2003; s. 68-9.
22.
Cünhan Ö. Oral ve Maksillofasiyal Patoloji. Ankara: Atlas, 2001; s. 27, 59-83.
23. Sirois DA. Fatahzadeh M, Roth R, Etlin D. Diagnostic Patterns and Delays in Pemphigus Vulgaris: Experience with 99 Patients. Arch Dermatol, 2000; 136(12): 1569-70.
24. Ahmed AR, Graham J, Jordan RE, Provost TT. Pemphigus: Current Concepts. Ann Intern Med, 1980; 92: 396-405.
25. Stoopler ET, Sollecito TP, DeRossi SS. Desquamative Gingivitis: Early Presenting Symptom of Mucocutaneous Disease. Quintessence Int, 2003; 34 (8): 582-586.
26. Mariotti A. Desquamative Gingivitis: Revisited. Todays FDA, 1991:3: 1C-2C.
27. Henry JB. Clinical Diagnosis and Management by Laboratory Methods, ed 20. Philadelphia: WB Saunders, 2001; p. 1002.
28. Ünür M, Büyükbabani N, Bektaş K, Demirez E. Pemfigus Vulgariste Öncü Ağız Lezyonlan. Akademik Dental Dişhekimliği Dergisi, 2003; 5 (3): 28-31.
29. Nousari CH, Brodsky R, Anhalt GJ. Evaluating the Role of Immunoablative High-Dose Cyclophosphamide Therapy in Pemphigus Vulgaris. J Am Acad Dermatol, 2003;49:148-150.
30. Mignogna MD, Lo Muzio L. Ruoppo E, Fedele S, Lo Russo L, Bucci E. High-Dose Intravenous 'Pulse' Methylprednisolone in the Treatment of Severe Oropharyngeal Pemphigus: a Pilot Study. J Oral Pathol Med, 2002; 31 (6): 339-344.
31. Ahmed AR, Dahi MV. Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in the Treatment of Autoimmune Mucocutaneous Blistering Diseases. Arch Dermatol, 2003; 139 (8): 1051-9.
42
Zeynep BOY, Kıvanç BEKTAŞ, Meral ÜNÜR
32. Ruocco V, Rossi A, Argenziano G. Aatarita C, Alviggi L, Farzati B, Papaleo G. Pathogenicity of the Intercellular Antibodies of Pemphigus and their Periodic Removal from the Circulation by Plasmapheresis. Br J Dermatol, 1978; 98 (2): 237¬41.
33. Lüftl M, Stauber A, Mainka A, Klingel R, Schuler G, Hertl M. Successful Removal of Pathogenic Autoantibodies in Pemphigus by Immunoadsorption with a Tryptophan-linked Polyvinylalcohol Adsorber. Br J Dermatol, 2003; 149 (3): 598-605.
34. Zegarelli DJ, Zegarelli EV. Intraoral Pemphigus Vulgaris. Oral Surg, 1977; 44: 384.
35. Kanwar J, Dhar S. Factors Responsible for Death in Patients with Pemphigus. J Dermatol. 1994; 21: 655¬9.
36. Savin J. Corticosteroids and Death in Pemphigus. J Am Acad Dermatol, 1983; 9 (2): 275.
37. Mutasim DF. Managament of Autoimmune Bullous Diseases: Pharmacology amd Therapeutics. J Am Acad Dermatol, 2004; 51: 859-77.
38. Robinson JC, Lozada-Nur F, Frieden I. A Review of the Literature and a Report on the Management of 12 Cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997; 84: 349-55.
39. Lozada-Nur F, Miranda C, Maliksi R. Double-Blind Clinical Trial of 0.05% Clobetasol Propionate Ointment in Orabase and 0.05% Fluocinonide Ointment in Orabase in the Treatment of Patients with Oral Vesiculoerosive Diseases. Oral Surg Oral Med Oral Pathol, 1994; 77: 598-604.
40. Pierard GE. Pierard-Franchimont C, Ben Mosbah T, Arrese Estrada J. Adverse Effects of Topical Corticosteroids. Acta Derm Venereol. Suppl (Stockh), 1989; 151: 26-30: discussion 47-52.
41. Weinberg MA, Insler MS, Campen RB. Mucocutaneous Features of Autoimmune Blistering Diseases. Oral Med Oral Pathol Oral Radiol Endod. 1997; 84 (5): 517-34.

Thank you for copying data from http://www.arastirmax.com